Shuichi Shimada
Overview
Explore the profile of Shuichi Shimada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
122
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jinnin M, Shimokawa T, Kishi A, Hayashi N, Nagahama M, Kubo A, et al.
J Dermatol
. 2025 Mar;
PMID: 40040594
The efficacy, safety, and optimal concentration of topical sirolimus gel for treatment of cutaneous lesions of vascular anomalies requires evaluation. This study was a multicenter, double-blind, placebo-controlled, parallel-group, phase II...
2.
Koyama J, Sato T, Sato Y, Sato S, Shimada S, Taniuchi S, et al.
IJU Case Rep
. 2024 Nov;
7(6):467-470.
PMID: 39498190
Introduction: Pelvic arteriovenous malformation is often a source of intraoperative bleeding. Here, we report our experience with a case of ureteral cancer with pelvic arteriovenous malformation treated using laparoscopic nephroureterectomy...
3.
Morozumi K, Kawasaki Y, Sato T, Maekawa M, Takasaki S, Shimada S, et al.
Metabolites
. 2024 Mar;
14(3).
PMID: 38535330
Tyrosine kinase inhibitors (TKIs) play a crucial role in the treatment of advanced renal cell carcinoma (RCC). However, there is a lack of useful biomarkers for assessing treatment efficacy. Through...
4.
Kashiwada-Nakamura K, Noguchi H, Yaguchi T, Urata K, Shimada S, Sawamura S, et al.
Mycopathologia
. 2024 Jan;
189(1):9.
PMID: 38231396
No abstract available.
5.
Sato Y, Kawasaki Y, Satake Y, Shimoda Y, Katayama H, Sato T, et al.
Case Rep Oncol
. 2023 Dec;
16(1):1573-1578.
PMID: 38089733
Although the response to combination therapy has been reported in patients with brain metastases from advanced renal cancer, treatment-related cerebral hemorrhage has not been adequately studied. The CheckMate 9ER clinical...
6.
Yamamoto T, Umezawa R, Shimada S, Takahashi N, Takeda K, Suzuki Y, et al.
Anticancer Res
. 2023 Nov;
43(11):5115-5125.
PMID: 37909950
Background/aim: This retrospective study aimed to investigate the outcomes of relapse-free survival (RFS) after salvage radiation therapy (SRT) to the prostate bed for postoperative biochemical recurrence of prostate cancer. Patients...
7.
Kuriyama H, Myangat T, Kajihara I, Shimada S, Kimura T, Sawamura S, et al.
J Dermatol
. 2023 Oct;
51(4):e110-e111.
PMID: 37870255
No abstract available.
8.
Shimada S, Mijiddorj M, Kajihara I, Maeda-Otsuka S, Sawamura S, Yamada-Kanazawa S, et al.
J Dermatol
. 2023 Oct;
51(3):e70-e71.
PMID: 37795802
No abstract available.
9.
Shimada S, Myangat T, Kajihara I, Sawamura S, Makino K, Aoi J, et al.
J Dermatol
. 2023 Apr;
50(9):e301-e302.
PMID: 37073108
No abstract available.
10.
Yamada-Kanazawa S, Shimada S, Nakayama W, Sawamura S, Nishimura Y, Kajihara I, et al.
Drug Discov Ther
. 2023 Feb;
17(1):70-72.
PMID: 36843077
We studied 95 patients with infantile hemangioma (IH) treated with propranolol at the Department of Dermatology, Kumamoto University Hospital, from November 2016 to January 2022, based on sex, site, clinical...